Follow
James Buchanan
James Buchanan
Verified email at qmul.ac.uk
Title
Cited by
Cited by
Year
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
K Schwarze, J Buchanan, JC Taylor, S Wordsworth
Genetics in Medicine 20 (10), 1122-1130, 2018
5242018
The challenge of antimicrobial resistance: what economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), eaau4679, 2019
3822019
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care—Preliminary Report
100,000 Genomes Project Pilot Investigators
New England Journal of Medicine 385 (20), 1868-1880, 2021
3592021
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
K Schwarze, J Buchanan, JM Fermont, H Dreau, MW Tilley, JM Taylor, ...
Genetics in Medicine 22 (1), 85-94, 2020
2072020
Issues surrounding the health economic evaluation of genomic technologies
J Buchanan, S Wordsworth, A Schuh
Pharmacogenomics 14 (15), 1833-1847, 2013
1232013
Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective?
S Wordsworth, J Buchanan, J Mollison, K Harrild, L Robertson, C Tay, ...
Human reproduction 26 (2), 369-375, 2011
662011
Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions
KA Phillips, PA Deverka, DA Marshall, S Wordsworth, DA Regier, ...
Value in Health 21 (9), 1033-1042, 2018
652018
Women’s birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature
J Hollowell, Y Li, R Malouf, J Buchanan
BMC pregnancy and childbirth 16, 1-17, 2016
592016
Valuation of health and nonhealth outcomes from next-generation sequencing: Approaches, challenges, and solutions
DA Regier, D Weymann, J Buchanan, DA Marshall, S Wordsworth
Value in Health 21 (9), 1043-1047, 2018
572018
Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers
J Buchanan, S Wordsworth, T Ahmad, A Perrin, S Vermeire, M Sans, ...
Journal of Crohn's and Colitis 5 (4), 301-316, 2011
562011
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom
S Wordsworth, J Buchanan, R Regan, V Davison, K Smith, S Dyer, ...
Genomic medicine 1, 35-45, 2007
432007
Availability and funding of clinical genomic sequencing globally
KA Phillips, MP Douglas, S Wordsworth, J Buchanan, DA Marshall
BMJ global health 6 (2), e004415, 2021
422021
Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling
DA Marshall, LR Grazziotin, DA Regier, S Wordsworth, J Buchanan, ...
Value in Health 23 (5), 566-573, 2020
422020
Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?
J Buchanan, S Wordsworth
PharmacoEconomics 33 (6), 571-9, 2015
372015
Patients’ Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment
J Buchanan, S Wordsworth, A Schuh
The Patient-Patient-Centered Outcomes Research 9 (6), 525-536, 2016
322016
A review of the challenges of using biomedical big data for economic evaluations of precision medicine
P Fahr, J Buchanan, S Wordsworth
Applied health economics and health policy 17 (4), 443-452, 2019
302019
Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study.
L Pankhurst, L Macfarlane-Smith, J Buchanan, L Anson, K Davies, ...
Health technology assessment (Winchester, England) 18 (53), 1, 2014
302014
Toward the diagnosis of rare childhood genetic diseases: what do parents value most?
S Pollard, D Weymann, J Dunne, F Mayanloo, J Buckell, J Buchanan, ...
European Journal of Human Genetics 29 (10), 1491-1501, 2021
272021
Urgent improvements needed to diagnose and manage Lynch syndrome.
KJ Monahan, D Alsina, S Bach, J Buchanan, J Burn, S Clark, P Dawson, ...
Bmj 356, 2017
262017
Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options
R Koleva-Kolarova, J Buchanan, H Vellekoop, S Huygens, M Versteegh, ...
Applied Health Economics and Health Policy 20 (4), 501-524, 2022
252022
The system can't perform the operation now. Try again later.
Articles 1–20